MarketCap
Facebook
X
Telegram
Celsion Corporation PEG Ratio | CLSN
Annual PEG Ratio Celsion Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -0.000473 | -0.00902 | -0.00402 | -0.0163 | -0.157 | 0.143 | -0.0422 | -0.0117 | -0.0256 | -0.0505 | 0.0354 | -0.0854 | -0.333 | 0.000081 | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.143 | -0.333 | -0.0398 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Brickell Biotech
BBI
|
-0.00431 | - | -5.38 % | $ 6.06 M |  USA |
 |
Applied Therapeutics
APLT
|
0.243 | - | - | $ 8.42 M | USA |
 |
ESSA Pharma
EPIX
|
0.151 | - | - | $ 8.86 M |  Canada |
 |
Generation Bio Co.
GBIO
|
-0.476 | - | - | $ 344 M | USA |
 |
Clearside Biomedical
CLSD
|
-0.00335 | - | - | $ 25.3 M | USA |
 |
Merus N.V.
MRUS
|
923 | - | - | $ 5.78 B |  Niderland |
 |
RAPT Therapeutics
RAPT
|
0.059 | - | - | $ 2.36 B | USA |
 |
Annexon
ANNX
|
0.176 | $ 4.21 | 4.99 % | $ 653 M | USA |
 |
AbbVie
ABBV
|
21.1 | $ 291.22 | 1.06 % | $ 515 B | USA |
 |
22nd Century Group
XXII
|
-0.000003 | $ 1.56 | -19.17 % | $ 287 K | USA |
 |
Axon Enterprise
AXON
|
0.171 | $ 313.68 | -18.01 % | $ 24.5 B | USA |
 |
Biogen
BIIB
|
-1.72 | $ 248.51 | 1.88 % | $ 36.4 B | USA |
 |
BioLineRx Ltd.
BLRX
|
60 | $ 1.73 | -2.15 % | $ 4.26 B |  Israel |
 |
Theratechnologies
THTX
|
-0.116 | - | - | $ 83.9 M | Canada |
 |
Exelixis
EXEL
|
-2.14 | $ 69.55 | 1.22 % | $ 18.9 B | USA |
 |
Geron Corporation
GERN
|
1.04 | $ 0.99 | 3.97 % | $ 660 M | USA |
 |
Gilead Sciences
GILD
|
0.24 | $ 166.9 | -0.4 % | $ 208 B | USA |
 |
Grifols, S.A.
GRFS
|
-0.048 | $ 8.46 | -0.12 % | $ 5.75 B |  Spain |
 |
Alnylam Pharmaceuticals
ALNY
|
-0.955 | $ 155.97 | -0.44 % | $ 20.4 B | USA |
 |
InflaRx N.V.
IFRX
|
0.094 | $ 1.31 | -3.69 % | $ 88.1 M |  Germany |
 |
INmune Bio
INMB
|
-0.0294 | $ 1.12 | -4.68 % | $ 27.7 M | USA |
 |
Insmed Incorporated
INSM
|
-1.28 | $ 114.55 | 5.32 % | $ 22.8 B | USA |
 |
Johnson & Johnson
JNJ
|
74.2 | $ 274.89 | 0.95 % | $ 662 B | USA |
 |
Titan Pharmaceuticals
TTNP
|
-0.00348 | - | -3.76 % | $ 3.47 M | USA |
 |
Lineage Cell Therapeutics
LCTX
|
-0.158 | $ 1.02 | 3.75 % | $ 235 M | USA |
 |
BioVie
BIVI
|
-0.000198 | $ 1.33 | 9.92 % | $ 1.96 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
0.0566 | - | 3.16 % | $ 1.9 M | USA |
 |
TCR2 Therapeutics
TCRR
|
-0.373 | - | - | $ 58.1 M | USA |
 |
Crinetics Pharmaceuticals
CRNX
|
-0.497 | $ 84.95 | 0.13 % | $ 7.99 B | USA |
 |
Mustang Bio
MBIO
|
-0.00287 | $ 0.39 | 0.15 % | $ 1.91 M | USA |
 |
TFF Pharmaceuticals
TFFP
|
-0.000577 | - | -60.05 % | $ 125 K | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-0.000013 | $ 1.63 | 1.87 % | $ 2.68 M | Israel |
 |
Mesoblast Limited
MESO
|
1.3 | $ 14.26 | 1.13 % | $ 17.2 B |  Australia |
 |
Mirum Pharmaceuticals
MIRM
|
6.53 | $ 93.81 | 0.28 % | $ 4.71 B | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
-0.00126 | - | -15.15 % | $ 60.3 M |  Britain |
 |
AVEO Pharmaceuticals
AVEO
|
-0.0315 | - | - | $ 521 M | USA |
 |
Codexis
CDXS
|
-0.174 | $ 1.09 | 6.37 % | $ 95 M | USA |
 |
MannKind Corporation
MNKD
|
2.51 | $ 3.91 | 4.0 % | $ 1.2 B | USA |
 |
MediciNova
MNOV
|
3.01 | $ 1.44 | -0.69 % | $ 70.7 M | USA |
 |
Axcella Health
AXLA
|
-0.0713 | - | -16.42 % | $ 249 M | USA |
 |
Merck & Co.
MRK
|
1.18 | $ 146.81 | -0.07 % | $ 367 B | USA |
 |
Dynavax Technologies Corporation
DVAX
|
-0.688 | - | - | $ 2.02 B | USA |
 |
Tyme Technologies
TYME
|
-0.0215 | - | 8.07 % | $ 54 M | USA |
 |
Curis
CRIS
|
-0.00281 | $ 0.88 | 3.67 % | $ 11.6 M | USA |
 |
Cyclerion Therapeutics
CYCN
|
-0.0574 | $ 34.99 | 3.77 % | $ 147 M | USA |
 |
Завод ДИОД
DIOD
|
-0.421 | - | - | - |  Russia |
 |
CorMedix
CRMD
|
0 | $ 5.31 | 1.43 % | $ 383 K | USA |
 |
Novartis AG
NVS
|
1.25 | $ 162.64 | 0.44 % | $ 315 B |  Schweiz |
 |
CRISPR Therapeutics AG
CRSP
|
0.0973 | $ 50.09 | 3.15 % | $ 4.5 B | Schweiz |